Lidocaine Hci Injection, Solution
Product Images NDC 51662-1419

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lidocaine Hci (NDC 51662-1419). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

Description (Description)
This appears to be a table showing the concentrations of the medications Epinephrine, Lidocaine HCI, and Sodium Chloride at different ratios and percentages. The table shows the amount of each medication in milligrams per milliliter for different ratios and percentages. This information could be useful in determining the appropriate dose of medication for a given medical procedure.*
FDA Label Image

Dosage Table (Dosage Table)

Dosage Table (Dosage Table)
This is a table displaying recommended dosages for Lidocaine Hydrochloride Injection, USP without epinephrine for various procedures such as infiltration, intravenous regional, peripheral nerve blocks, sympathetic nerve blocks, and central neural blocks including Epidural® for both analgesia and anesthesia purposes. The recommended dosages are specified in terms of concentration, volume, and total dose in mg.*
FDA Label Image
FDA Label Image

How Supplied (How Supplied)

How Supplied (How Supplied)
This is a list of various sizes and concentrations of Lidocaine HCI and Epinephrine marketed for medical use in the form of Fliptop Vials or Ampuls, which are trays or cases of multiple doses, for both single and epidural test doses. The concentrations available in the products range from 0.5% to 2%, with Epinephrine ranging from 1:100,000 to 1:200,000.*
FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
This text contains a list of different classes of drugs along with representative examples of each class, including nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs such as acetaminophen, metoclopramide, quinine, and sulfasalazine.*
FDA Label Image

Serialized Labeling (Serialized Labeling)

Serialized Labeling (Serialized Labeling)
This appears to be a medication label with a code number and manufacturing information. Specifically, it includes the name of the manufacturer, dosage, and administration instructions. It also highlights a caution to avoid use in infiltration, nerve block, epidural, or caudal procedures. The medication is distributed by HF Acquisition Co., LLC in Mukilteo, WA.*
FDA Label Image
FDA Label Image

Structure 1 (Structure 1)

FDA Label Image

Structure 2 (Structure 2)

FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)
This is a description of a 50 mL multiple-dose injection of Lidocaine HCI 1% and Epinephrine 1:100,000 intended for infiltration and nerve block. This injection should not be used for epidural or caudal use. The lot number is HH#-HHH-AA with an expiration date of DMMMYYYY, and it is only available for prescription. Each mL of this injection contains lidocaine HCJ, anhyd. 10 mg; epinephrine 10 meg; NaC17 mg; sodium metabisulite 05 mg, ciric acid, anhyd. 02 mg, and methylparaben 1 mg. It may contain NaOH and/or HC! for pH adjustment. The pH level is 4.5 (33 to 55). It is described as sterile and non-pyrogenic. There are specific instructions for dosage on an insert provided with the injection, and it is not recommended to be autoclaved. The product is distributed by Hospia, Inc. of Lake Forest, IL 60045, USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.